戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ate activated AKT as a tumorigenic driver in ganglioneuroma.
2 al nerve sheath tumor (PNST) that arose in a ganglioneuroma.
3 ude neuroblastoma, ganglioneuroblastoma, and ganglioneuroma.
4 tomas, musculoskeletal anomalies and mucosal ganglioneuromas.
5 ing from immature malignant tumors to benign ganglioneuromas.
6  distal colonic aganglionosis and intestinal ganglioneuromas.
7 he disease course and clinical management of ganglioneuromas.
8                        Patients who had >/=1 ganglioneuroma (29% vs 2%; P < .001) or presented with p
9 onal cell vitronectin was detected in 7 of 9 ganglioneuromas, 5 of 8 peripheral ganglia, and 14 of 21
10                 The child was diagnosed with ganglioneuroma and embryonal rhabdomyosarcoma (ERMS) at
11 ies that could reduce the size and extent of ganglioneuroma and therefore limit surgical morbidity.
12 kemias, osteosarcomas, Ewing's sarcomas, and ganglioneuromas and in normal tissues.
13                                              Ganglioneuromas and occasional neuroblastomas formed in
14 chromocytoma and malignant PNST arising in a ganglioneuroma appear to be nonspecific.
15                                         Most ganglioneuromas are asymptomatic and found incidentally.
16                                              Ganglioneuromas are rare tumors derived from neural cres
17 f mTOR inhibitors as a means to shrink large ganglioneuromas before resection in order to reduce surg
18 retroperitoneal, intra-abdominal, and pelvic ganglioneuromas between January 1, 2000, and January 1,
19 t an AKT-mTOR-S6 pathway was active in human ganglioneuroma but not neuroblastoma samples.
20 Homozygotes did not develop gastrointestinal ganglioneuromas, but displayed ganglioneuromas of the ad
21 patients with malignant PNST that arose in a ganglioneuroma, contrast-enhanced CT showed a large, mar
22 wnstream AKT target, mTOR, in zebrafish with ganglioneuroma effectively reduced the tumor burden.
23 ected identical band shifts in the leukemia, ganglioneuroma, ERMS, and normal tissues, consistent wit
24                                              Ganglioneuroma (GN) is a rare benign tumor arising from
25                                         Most ganglioneuromas have indolent disease courses and rarely
26 al tumors, histologically identical to human ganglioneuromas, in their sympathetic nervous systems an
27                              Retroperitoneal ganglioneuroma is a rare bening tumor, generally asympto
28 trointestinal ganglioneuromas, but displayed ganglioneuromas of the adrenal medulla, enlargement of t
29  and adrenal chromaffin cells, together with ganglioneuromas of the gastrointestinal tract and other
30 is syndrome associated with gastrointestinal ganglioneuromas of unknown etiology.
31                         Findings in cases of ganglioneuroma-pheochromocytoma and malignant PNST arisi
32             CT findings in two patients with ganglioneuroma-pheochromocytoma included central necrosi
33  nine patients with ganglioneuroma, two with ganglioneuroma-pheochromocytoma, and two with malignant
34  NBL, 12 ganglioneuroblastoma (GNBL), and 20 ganglioneuroma samples in a multivariate model.
35                                      In most ganglioneuroma samples, a low percentage of tumor cells
36                                 Diagnosis of ganglioneuroma should be considered when typical CT or M
37 median follow-up of 1.9 years, with 92.2% of ganglioneuromas stable in size.
38 REPORT: We present a case of retroperitoneal ganglioneuroma that mimicked renal mass on imaging.
39                        In nine patients with ganglioneuroma, the mass ranged in size from 2 x 4 x 4 c
40 ed of imaging findings in nine patients with ganglioneuroma, two with ganglioneuroma-pheochromocytoma
41    Surgery is the only effective therapy for ganglioneuroma, which may be challenging due to the loca
42 athetic nervous system were found to develop ganglioneuroma without progression to neuroblastoma.